跳至主要内容
临床试验/IRCT20151227025726N21
IRCT20151227025726N21招募中3 期

Evaluating the effect of Acetazolamide on the prevention of post-operative Acute Kidney Injury (AKI) following Coronary Artery Bypass Grafting (CABG) surgery

Shahid Beheshti University of Medical Sciences0 个研究点目标入组 70 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
70

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 80 years(—)
性别
All

入选标准

  • It will be performed on patients who refer to Masih Daneshvari and Modares Hospital for Coronary Artery Bypass Surgery (CABG).

排除标准

  • History of any allergies to any of the compounds in acetazolamide tablets and sulfonamide compounds
  • Liver failure (stage II, III or liver enzymes more than 3 times)
  • Chronic renal failure (Stage IV & V CKD) or patients with serum creatinine less than 30 ml / min, anorexia
  • Chronic heart failure (Ejection Fraction <30)
  • Patients undergoing CABG surgery for emergency reasons.
  • Hypokalemia (potassium less than 3.3 mmol / L), hyponatremia (sodium less than 135 mmol / L)
  • Gout attack

研究者

相似试验

Evaluating the effect of Acetazolamide on the... | 临床试验